FUTURE OF HEALTHCARE, MEDICAL DEVICES
LivaNova | February 03, 2023
On February 02, 2023, LivaNova PLC, a medical innovation and technology company, has launched an implantable pulse generator (IPG) SenTiva DUO™, useful for VNS Therapy™ of drug-resistant epilepsy.
With a dual-pinned header, it offers similar therapeutic benefits as SenTiva, the company's earlier product, which stimulates a response to the rapid heart rate, which can be a result of seizures, the low heart rate, and similar situations with day and night programming and scheduled programming. It recently received 510(k) clearance from the United States Food and Drug Administration and is now available for purchase in the United States.
Professor and Chief Pediatric Neurology at Le Bonheur Children's Hospital in Memphis, Tennessee, Dr. James Wheless, said, "This new offering enables those VNS Therapy patients with legacy dual-pin systems to have the option to replace their device with SenTiva DUO, delivering the most advanced VNS Therapy treatment without the need for lead revision." He added, "Having access to SenTiva DUO offers patients therapy that can be customized and delivered automatically, providing optimal seizure control and enabling maximum adherence to treatment."
(Source – Business Wire)
Chief Executive Officer of LivaNova, Damien McDonald, said, "We're proud to offer SenTiva DUO to serve patients who were early adopters of VNS Therapy many years ago. Over time, all VNS Therapy patients must replace their generators as batteries become depleted. Now, our 'pioneer patients' will be able to take advantage of the latest technology with SenTiva DUO and experience the full benefits of VNS Therapy, without the need to replace their dual-pin lead."
(Source – Business Wire)
About LivaNova
LivaNova PLC is transforming the lives of patients all over the world with its innovation and technological advancements in the medical field, providing clinical and financial support by offering various products and a global reach. Its advanced technologies and revolutionary treatment solutions have benefited healthcare professionals, healthcare systems, and patients worldwide. Headquartered in London (UK), it has about 3,000 employees worldwide and a presence in over 100 countries. Its products work for therapeutic areas like advanced circulatory support, cardiopulmonary, obstructive sleep apnea, heart failure, difficult-to-treat depression (DTD), and drug-resistant epilepsy.
Read More
HEALTH TECHNOLOGY, DIGITAL HEALTHCARE
CCS | February 02, 2023
On February 1, 2023, CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, announced the launch of its Scientific Advisory Council, comprised of four industry leaders who will assist CCS in its commitment to reinventing patient care at home through a more holistic approach. The Council consists of Karmeen Kulkarni, MS, RD, CD, CDCES, BC-ADM; Alexander Ding, MD, MBA; Steven Wittlin, MD; and Francine Kauffman, MD. This announcement follows the appointment of Arti Masturzo, MD, as CCS's first Chief Medical Officer.
Over 11% of the US population has been diagnosed with diabetes, which is projected to increase among American youth and young adults. Therefore, there is a great need for innovative technologies, partnerships, and services to fully support people in managing their diabetes. CCS chose to assemble its Scientific Advisory Council and assume a leadership position in redefining how health plans, providers, and employers support their patients and members impacted by costly, debilitating chronic diseases.
Additional information about the initial members of the Council is provided below
• Alexander Ding, MD, MBA, is a diagnostic and interventional radiologist, Associate VP of Physician Strategy and Medical Affairs for Humana, and an American Medical Association board member. He cultivates physician-health plan relationships and patient empowerment and engagement through digital health.
• Karmeen Kulkarni, MS, CD, RD, CDCES, BC-ADM, is a clinical pioneer in diabetes management with over 30 years of experience. She was Abbott's Global Scientific Affairs director for 15 years before starting her consulting firm. Ms. Kulkarni has unique experience integrating devices, technology, coaching, and clinical services to improve outcomes for diabetes patients.
• Steven Wittlin, MD, is an endocrinologist, published author, and University of Rochester's Director of Diabetes Services. His experience includes new diabetes treatment procedures that combine best practices in technology, medical devices, and clinical services.
• Francine Kaufman, MD, a pediatric endocrinologist, and former American Diabetes Association president, is the Chief Medical Officer at Senseonics, Inc., and previously held that position at Medtronic Diabetes. Dr. Kaufman, a key CCS Strategic Advisory Board member, will also be on the Scientific Advisory Council.
About CCS
Based in Dallas, Texas, CCS provides collaborative care programs and medical supplies delivered at home for people with chronic conditions, particularly diabetes. As a result, patients have better probabilities of starting and continuing therapy with CCS as their partner, lowering costs and enhancing outcomes. The company serves over 150,000 people in the United States with chronic conditions and delivers over 1.2 million medical products to homes yearly. With over 25 years of experience, CCS has the expertise, data, and relationships to usher in a new era of home-based, proactive chronic care management.
Read More
FUTURE OF HEALTHCARE, MEDICAL DEVICES
XSOLIS | February 01, 2023
On January 31, 2023, AnMed has chosen XSOLIS, the artificial intelligence company supporting healthcare systems, to remodel its utilization management across its health systems.
The XSOLIS' CORTEX platform will share real-time clinical data across its connected network of providers and players. Due to the shortage of nursing staff and increased number of patients, a technology solution would provide accurate patient status from the beginning to minimize rejections and associated interactions with payers.
XSOLIS will centralize AnMed's operations, track work over its three hospitals, and connect its Physician Advisor and Utilization Management teams. In addition, CORTEX's advanced case management analytics and reporting efficiencies with AnMed's electronic medical record system will enhance the leverage time of the hospital systems.
Associate Vice President of Population Health at AnMed, Suzanne Wilson, said, "When evaluating next-generation utilization management platforms, XSOLIS was in a league of its own. The healthcare industry has reached a tipping point, where improved provider-payer relations are imperative to reduce administrative waste and unnecessary friction. XSOLIS will help us achieve just that through its innovative technology."
(Source – Cision PR Newswire)
Chief Financial Officer at AnMed, Christine Pearson, said, "This is a challenging time for provider organizations across the U.S. By providing an automated, objective view of medical necessity, XSOLIS will help increase the efficiency of our existing staff so that we can better serve our patients."
(Source – Cision PR Newswire)
CEO and Co-Founder at XSOLIS, Joan Butters, said, "There is a growing need for transformative solutions as providers continue to contend with a shortage of healthcare professionals and friction across the healthcare system. We're looking forward to helping AnMed transform their operations to work more efficiently internally, as well as with payer organizations."
(Source – Cision PR Newswire)
About XSOLIS
XSOLIS, the technology solutions and data science platform, serves hospitals and payer organizations nationwide for effective healthcare systemization, enhancing data-driven decision-making and collaboration with providers and payers. Its CORTEX, an AI platform, uses real-time predictive analytics to continuously objectify medical needs and care with appropriate settings. In addition, it offers patient status evaluation through health systems, reduces the administrative burden of hospitals, and increases automation between payers, health plans, and providers-sponsored health plans (PSHPs), inpatient as well as observation status.
About AnMed
AnMed, a non-profitable health system upstate in northeast Georgia and South Carolina, includes four hospital systems: AnMed Cannon in Pickens, AnMed Women's and Children's Hospital, and AnMed Rehabilitation Hospital with around 3,700 employees and 400 physicians. It provides routine care, urgent care as the requirement, life-saving emergency treatment, specialized care, home health visits, and virtual visits, as well as options to schedule an appointment, pay bills, volunteer, access medical records, donate, and find a job in its hospital systems.
Read More